* Corresponding Author
Effect of advanced-platelet rich-fibrin combined with rosuvastatin application after open flap debridement of infrabony pocket
https://doi.org/10.22146/majkedgiind.53419 Tissa Rahadianti(1), Dahlia Herawati(2), Kwartarini Murdiastuti(3*)
(1) Periodontics Specialty Program, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(2) Department of Periodontics, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(3) Department of Periodontics, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author
Abstract
Open flap debridement (OFD) is an invasive therapy for chronic periodontitis with pocket 5 mm or more. However, it is difficult to achieve regeneration and new attachment with this therapy. Periodontitis starts to add growth factors and local drugs delivery as host modulation therapy. Advanced-PRF (A-PRF) contains more growth factor than PRF which plays a role in promoting fibroblast proliferation, reepithelization, extracellular matrix production, and endothelial cell migration. 1.2% rosuvastatin gel (RSV) is a local delivery drug with a pleiotropic effect that can modify host response to promoting BMSCs, BMP-2, OPG, ALP, RANKL, and osteoblasts. This study aimed to examine the effect of the application of A-PRF+RSV in OFD therapy of which the parameters were probing depth (PD), relative attachment loss (RAL), and alveolar bone height. The study samples consisted of 24 periodontal pockets which were divided into 2 groups of 12 pockets each, namely A-PRF+RSV for group 1 and PRF+RSV for group 2. Clinical evaluations were carried out on baseline, day-30, and day-90 for PD and RAL, and on baseline and day -90 for alveolar bone height. Data of PD and RAL reduction were analyzed with non-parametric test Mann-Withney, while data of reduction of alveolar bone height were analyzed with parametric Independent-T test. Group 1 obtained a statistically more significant result in reducing PD, RAL, and alveolar bone height compared to group 2 (p<0.05) To conclude, the application of A-PRF and 1.2% rosuvastatin gel in OFD procedure promotes a higher PD and RAL reduction and alveolar bone height increase than the application of PRF coupled with 1.2% rosuvastatin gel.
Keywords
Full Text:
PDFReferences
1. Fadhilah ND, Ulfiana R, Putri FA. Peran periodontitis terhadap patogenesis penyakit
alzheimer. BIMKGI. 2016; 4(1): 33-36.
2. Ausenda F, Rasperini G, Acunzo R, Gorbunkova A, Pagni G. New perspectives
in the use of biomaterials for periodontal regeneration. Materials (Basel). 2019; 12(13):
2197-2217. doi: 10.3390/ma12132197
3. Geurs N, Lacono V, Krayer J, Mealey B, Paquette D, Pearson B, Rosen P,
Schweinebraten MS. American Academy of Periodontology task force report on the update
to 1999 classification of periodontal disease and conditions. J Periodontal. 2015; 86(7):
835-838. doi: 10.1902/jop.2015.157001
4. Pradeep AR, Garg V, Kanoriya D, Singhal S. Platelet-rich fibrin with 1.2% rosuvastatin for
the treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical
trial. J Periodontol. 2016; 87(12): 1468-1473. doi: 10.1902/jop.2016.160015
5. Borie E, Olivi DG, Orsi LA, Garlet K, Weber B, Beltran V, Fuentes R. Platelet-Rich fibrin
application in dentistry: a literature review. Int J Clin Exp Med. 2015; 8(5): 7922-7929.
6. Rathod S, Wanikar I, Paralikar A. Soft and hard tissue changes after the placement of
smart blood platelet-rich fibrin derivative into intrabony defects: a systematic review and
meta-analysis with at least. J Int Clin Dent Res Organ. 2018; 10(2): 49-58.
doi: 10.4103/jicdro.jicdro_10_18
7. Chandran P, Sivadas A. Platelet-rich fibrin: its role in periodontal regeneration. The Saudi
Journal for Dental Research. 2014; 5(2): 117-122. doi: 10.1016/j.ksujds.2013.09.001
8. Reynolds MA, Kao RT, Nares S, Camargo PM, Caton JG, Clem DS, Fiorellini JP,
Geisinger ML, Mills MP, Nevins ML, Rosen PS. Periodontal Regeneration - intrabony
defects: practical applications workshop from the aap regeneration. Clinical Advances in
Periodontics. 2015; 5(1): 21-29. doi: 10.1902/cap.2015.140062
9. Agrawal M, Agrawal V. Platelet rich fibrin and its applications in dentistry- a review article.
Natl J Med Dent Res. 2014; 2(3): 51-58.
10. Suwondo CI, Herawati D, Sudibyo. Effect of platelet-rich fibrin advanced applications
on periodontal regeneration in infrabony pocket treatments. Majalah Kedokteran Gigi
Indonesia. 2018; 4(3): 155-159. doi: 10.22146/majkedgiind.37414
11. Sulijaya BN, Takahashi, Yamazaki K. Host modulation therapy using anti-inflammatory
and antioxidant agents in periodontitis: a review to a clinical translation. Arch Oral
Biology. 2019; 105: 72-80. doi: 10.1016/j.archoralbio.2019.07.002
12. Elavarasu S, Suthanthiran TK, Naveen D. Statins: A New era in local drug delivery. J
Pharm Bioallied Sci. 2012; 4(2): 248-251. doi: 10.4103/0975-7406.100225
13. Kirzioglu FY, Bulut MT, Dogan B, Fentoglu O, Ozmen O, Carsancak SA, Ergun Ag,
Ozdem M, Orhan H. Anti-inflammatory effect of rosuvastatin decreases alveolar bone loss
in experimental periodontitis. J Oral Sci. 2017; 59(2): 247-255. doi: 10.2334/josnusd.16-0398
14. Petit C, Batool F, Bugueno IM, Schwinte P, Jessel NB, Huck O. Contribution of statin
towards periodontal treatment: a review. Mediators Inflamm. 2019; 2019: 6367402.
doi: 10.1155/2019/6367402
15. Preshaw PM. Host modulation therapy with anti-inlammatory agents. Singapore:
Periodontology 2000; 2017. 1-19.
16. Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, Landes C, Sader
R, Kirkpatrick CJ, Choukroun J. Advanced platelet-rich fibrin: a new concept for cell-based
tissue engineering by means of inflammatory cells. J Oral Implantol. 2014; 40(6): 679-689.
doi: 10.1563/aaid-joi-D-14-00138
17. Kobayashi E, Fluckiger L, Kobayashi MF, Sawada K, Sculean A, Schaller B, Miron RJ.
Comparative releas of Growth Factors from PRP, and Advanced-PRF PRF. Clin Oral
Investig. 2016; 20(9): 2353 -2360. doi: 10.1007/s00784-016-1719-1
18. Park JW, Hwang, Yoon SRIS. Advanced Growth Factor Delivery Systems in Wound
Management and Skin Regeneration. Molecules. 2017; 22(8): 1259-1279.
doi: 10.3390/molecules22081259
19. Millan ER, Navarro BG, Gomez KI, Roig AM, Salas EJ, Lopez JL, Ortega EV. The
application of statins in the regeneration of bone defects. Systematic review and metaanalyis.
Materials. 2019; 12(18): 2992. doi: 10.3390/ma12182992
20. Gonzalez ACO, Andrade ZA, Costa TF, Medrado ARAP. Wound Healing - a literature
review. An Bras Dermatol. 2016; 91(5): 614-620. doi: 10.1590/abd1806-4841.20164741
21. Borges CDA, Ricoldi MS, Messora MR, Palioto DB, Souza SLS. Clinical attachment
loss and molecular profile in inflamed sites before treatment. J Appl Oral Sci. 2019; 27:
1-10. doi: 10.1590/1678-7757-2018-0671
22. Newman MG, Takei HH, Klokkevold PR, Carranza, FA. Carranza’s Clinical Periodontology, 12th Edition. Missouri: Elsevier Saunders; 2015. 50-51.
23. Shinwari MS, Tanwir F, Hyder PR, Saeed HMB. Host modulation therapeutics in Periodontics:
Role as an adjunctive periodontal therapy. J Coll Physicians Surg Pak. 2014; 24(9): 676-684.
24. Zhang Q, Chen B, Guo J, Zhu X, Ma S, Yang W. Interleukin-10 inhibits bone resorption: a
potential therapeutic strategy in periodontitis loss and other bone diseases. Biomed
Research International. 2014; 2014: 284836. doi: 10.1155/2014/284836
25. Caymaz MG, Uyanik LO. Comparison of the effects of advanced platelet rich fibrin and
leukocyte- and platelet-rich fibrin on outcome after removal of impacted mandibular third
molar: A randomized split-mouth study. Niger J Clin Pract. 2019; 22(4): 546-552.
doi: 10.4103/njcp.njcp_473_18
26. Sumida R, Maeda T, Kawahara I, Yusa Y. Platelet-rich fibrin increases the osteoprogentaor/
receptor activator of nuclear factor-kB ligand ration in osteoblasts. Exp Ther Med. 2019;
18(1): 358-365. doi: 10.3892/etm.2019.7560
27. Toit JD, Gluckman H, Salama M. Platelet-Rich fibrin (PRF): a growth factor-rich biomaterials.
part 1 - the platelet concentrates milieu and review of the literature. International Dentistry
- African Edition. 2015; 5(5): 62-70.
DOI: https://doi.org/10.22146/majkedgiind.53419
Article Metrics
Abstract views : 1109
| 
views : 737
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Majalah Kedokteran Gigi Indonesia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.